American International Group, Inc. Xeris Biopharma Holdings, Inc. Transaction History

American International Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.04 - $3.22 $1,148 - $1,812	-563 Reduced 0.85%	65,577 $144,000
Q4 2023 Feb 13, 2024	SELL	$1.47 - $2.36 $392 - $630	-267 Reduced 0.4%	66,140 $155,000
Q3 2023 Nov 13, 2023	BUY	$1.8 - $2.69 $4,249 - $6,351	2,361 Added 3.69%	66,407 $123,000
Q2 2023 Aug 04, 2023	BUY	$1.82 - $2.98 $265 - $435	146 Added 0.23%	64,046 $167,000
Q1 2023 May 12, 2023	BUY	$1.03 - $1.63 $1,310 - $2,073	1,272 Added 2.03%	63,900 $104,000
Q4 2022 Feb 10, 2023	SELL	$1.14 - $1.65 $259 - $376	-228 Reduced 0.36%	62,628 $83,000
Q3 2022 Nov 14, 2022	BUY	$1.37 - $1.93 $1,216 - $1,713	888 Added 1.43%	62,856 $98,000
Q2 2022 Aug 12, 2022	BUY	$1.48 - $2.64 $91,712 - $163,595	61,968 New	61,968 $95,000

143

60M

148K

45.7K

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $462M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.